OLAXBT vs Enzyme — how do they compare? OLAXBT trades at Rp727.28 (market cap Rp167,81M, Rp15,83M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: OLAXBT is the larger of the two by market cap, and OLAXBT's supply is capped (230,3M / 1B AIO (24%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold OLAXBT for 3 Days and Enzyme for 29 Days on average.
| AIO | MLN | |
|---|---|---|
Market Cap | Rp167,81M | Rp134,13M |
Volume (24h) | Rp15,83M | Rp104,56M |
Circulating Supply | 230,3M / 1B AIO (24%) | 3,3M MLN |
Typical Hold Time | 3 Days | 29 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
OLAXBT is a decentralized AI trading platform that enables users to build and deploy automated trading agents through a modular, no-code infrastructure. Powered by its proprietary AIO Nexus Data Layer and Model Context Protocol (MCP), it supports real-time data access, standardized execution, and scalable agent interactions. The AIO token fuels payments, feature access, staking, and future governance within the ecosystem.
Read more on AIO →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →